banter and General Discussion, page-10519

And one more point, the long suffering holders of CYP are stuck in a share that they can't exit - especially if they are a Top 16 holder like sector.Today, a whole 2,214 shares in CYP traded at A20.5c.That's $A454 of value in the whole day!If CYP continues doing things that their shareholders don't like, the poor old shareholders just have to cop it - they can't exit and they just have to hope that CYP will magically come up with enough money to fund its trials through to completion, and then get the FDA to accept the highly modified Frankencells (how long is that gonna take??).Continued capital raises are likely and shareholders who don't stump up may continue to be diluted at lower and lower prices.So, it is very triggering for CYP when it appears that Meso is close to approval - which would make Meso even more protective of its patents and able to potentially freeze CYP and others out of orphan markets for 7 years.Being a CYP holder has been a pretty bleak experience.They were warned about all this back in 2019, when CYP had a 20% higher price than MSB, but the CYP holders chose to stick their heads in the sand, saying that we were ignorant and didn't understand the CYP business model. Well, it has now all come to pass and they are angry and looking for someone to blame - it can't be their own poor decision making and it couldn't possibly be the fault of their own beloved company, so they try to take it out on Meso.It's like they are barracking for a sports team.

ET

Aloha.